The latest announcement is out from BeiGene Ltd ( (HK:6160) ).
BeiGene, Ltd. has announced its 2025 Annual General Meeting of Shareholders, scheduled for May 21, 2025, in the Cayman Islands. The company will primarily use the Internet to distribute proxy materials, reflecting a shift towards digital communication with shareholders. This move may enhance accessibility and reduce costs, aligning with modern corporate governance practices.
More about BeiGene Ltd
BeiGene, Ltd. operates in the biotechnology industry, focusing on the development and commercialization of innovative cancer therapies. The company is listed on multiple stock exchanges, including Nasdaq, the Hong Kong Stock Exchange, and the Shanghai Stock Exchange, indicating its global market presence.
YTD Price Performance: 49.18%
Average Trading Volume: 3,926,812
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$240.1B
Find detailed analytics on 6160 stock on TipRanks’ Stock Analysis page.